← Back to Search

Localized Cancer Care for Multiple Myeloma

N/A

Recruiting

Led By Mark Fiala, Ph.D., MSW

Research Sponsored by Washington University School of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

At least 18 years old

Diagnosed with multiple myeloma

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through completion of follow-up (estimated to be 6 months)

Awards & highlights

Study Summary

This trial looks at how well patients like using satellite sites for treatment closer to home, and how it affects their travel times & expenses.

Who is the study for?

This trial is for adults over 18 with multiple myeloma who are currently being treated at the Siteman Cancer Center. They must live near a satellite site, speak English, and agree to participate. The study aims to see if receiving care closer to home can improve their experience.Check my eligibility

What is being tested?

The study is testing whether transitioning cancer care from the main Siteman Cancer Center to nearby satellite sites affects patient satisfaction and quality of life. It's comparing patients who make this transition against those who continue their care without change.See study design

What are the potential side effects?

Since this trial involves a change in the location of care rather than a medical intervention, there are no direct side effects related to treatments like drugs or surgery. However, changes in provider or facility may affect patient comfort or trust.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have been diagnosed with multiple myeloma.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through completion of follow-up (estimated to be 6 months)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through completion of follow-up (estimated to be 6 months)

This trial's timeline: 3 weeks for screening, Varies for treatment, and through completion of follow-up (estimated to be 6 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of eligible participants who successfully transfer to the provider at a satellite location

Secondary outcome measures

Financial toxicity of participants as measured by the Comprehensive Score for Financial Toxicity

Participant rationales for opting to transfer to a satellite site or maintain care at their usual site.

Satisfaction of with participant-provider interactions as measured by the Questionnaire on the Quality of Physician-Patient Interaction

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Care transitionExperimental Treatment1 Intervention

-At baseline, the participant and the provider will make a decision on if the participant will transfer care to a satellite location.

Group II: No care transitionActive Control1 Intervention

-At baseline, the participant and the provider will make a decision on if the participant will transfer care to a satellite location.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor

1,937 Previous Clinical Trials

2,299,575 Total Patients Enrolled

31 Trials studying Multiple Myeloma

2,097 Patients Enrolled for Multiple Myeloma

Mark Fiala, Ph.D., MSWPrincipal InvestigatorWashington University School of Medicine

Media Library

Care transition Clinical Trial Eligibility Overview. Trial Name: NCT05971056 — N/A

Multiple Myeloma Research Study Groups: Care transition, No care transition

Multiple Myeloma Clinical Trial 2023: Care transition Highlights & Side Effects. Trial Name: NCT05971056 — N/A

Care transition 2023 Treatment Timeline for Medical Study. Trial Name: NCT05971056 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants being recruited for this research endeavor currently?

"As per clinicaltrials.gov, this trial is not presently recruiting participants. It was first posted on August 1st 2023 and the most recent update was on July 30th of the same year. However, there are 814 other trials that are actively searching for candidates at present time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Providing Cancer Care Closer to Home for Patients With Multiple Myeloma

2023. "Providing Cancer Care Closer to Home for Patients With Multiple Myeloma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05971056.